BIVDA Press Releases

08Jul

BIVDA, ABPI and CRUK release briefing on new arrangements for commissioning and funding of six molecular diagnostic tests for cancer

BIVDA, ABPI and CRUK have released a stakeholder briefing to clarify the new arrangements for commissioning and funding of six molecular diagnostic tests for cancer in the NHS in England for 2016/17. 

It aims to provide NHS staff – be they commissioner or hospital provider financial staff, clinicians and pathology staff – with a clear understanding how the new funding arrangements for these tests in 2016/17 will operate to support timely and appropriate patient access. 

To read the full briefing, click here. For more information, contact BIVDA Chief Executive, Doris-Ann Williams.

Related

BIVDA Press Comment - Doris-Ann Williams welcomes Sajid Javid to his new position at DHSC

Please see below a quote from Doris-Ann Williams, CEO of BIVDA, welcoming the new Secretary of State...

Read More >

The British In Vitro Diagnostics Association (BIVDA) calls for vaccinations for industry frontline key workers

BIVDA represents the industry sector who manufacture and distribute diagnostic tests to the NHS. The...

Read More >

BIVDA Attends UN Meeting on Antimicrobial Resistance

Doris-Ann Williams MBE, Chief Executive of the British In Vitro Diagnostics Association (BIVDA), rep...

Read More >

BIVDA Celebrates Milestone 25th Anniversary

The British In Vitro Diagnostics Association (BIVDA) celebrated its milestone 25th Anniversary on Mo...

Read More >

UK Summit calls for hard evidence on In-Vitro Diagnostics

The 2nd annual UK Diagnostics Summit will take place yet again on November 8th this time at The Stra...

Read More >

Member Press Release - PulmoBioMed – a new medtech spin-out in the North East of England

PulmoBioMed – a new medtech spin-out in the North East of England Launched with funding f...

Read More >